New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareAdamax vs GHK

Adamax vs GHK

Side-by-side comparison of key properties, dosing, and research.

Cognitive Enhancement
Adamax
Skin & CosmeticAnti-Aging & Longevity
GHK
Summary
Adamax is a synthetic neuropeptide related to brain-derived neurotrophic factor (BDNF) signaling pathways. It is explored for cognitive enhancement, neuroprotection, and mood support, with proposed mechanisms involving TrkB receptor activation and enhancement of neuroplasticity similar to endogenous BDNF.
GHK is the natural tripeptide (Gly-His-Lys) released from human albumin that activates tissue remodeling, collagen synthesis, and anti-aging gene expression. The copper-free form is the biological signaling molecule; it chelates copper in tissue to form GHK-Cu but also has independent biological activity.
Half-Life
Estimated 1-3 hours (short; peptide degradation)
Extremely short as free peptide; tissue binding extends local effects
Admin Route
Subcutaneous, Intranasal (research)
SubQ, Topical, Oral
Research
Typical Dose
200-400 mcg per dose
100–500 mcg
Frequency
Once daily or every other day
Daily or 5x per week
Key Benefits
  • Proposed enhancement of learning and memory consolidation
  • Neuroprotective via BDNF-TrkB pathway support
  • May improve mood and resilience to stress
  • Potential support for neurogenesis
  • Cognitive clarity and focus enhancement (reported anecdotally)
  • Explored for neurodegeneration and age-related cognitive decline
  • Stimulates collagen and extracellular matrix synthesis
  • Activates tissue repair gene expression programs
  • Anti-aging: reverses 57% of age-related gene changes
  • Antioxidant and anti-inflammatory
  • Wound healing and skin barrier repair
  • Improves skin laxity, texture, and radiance
  • Neuroprotective (stimulates NGF, BDNF)
  • Anti-fibrotic in liver and lung models
Side Effects
  • Limited human safety data; largely anecdotal reports
  • Possible headache or mild overstimulation
  • Sleep disruption with late-day dosing
  • Unknown long-term safety profile
  • Excellent safety profile (naturally occurring peptide)
  • Rare: mild injection site reaction (SC)
  • No significant adverse effects identified in research
Stacks With